368 related articles for article (PubMed ID: 23728993)
1. Mini-review on glycolysis and cancer.
Akram M
J Cancer Educ; 2013 Sep; 28(3):454-7. PubMed ID: 23728993
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents.
Sheng H; Tang W
Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655
[TBL] [Abstract][Full Text] [Related]
3. Glycolysis inhibition for anticancer treatment.
Pelicano H; Martin DS; Xu RH; Huang P
Oncogene; 2006 Aug; 25(34):4633-46. PubMed ID: 16892078
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.
Xu RH; Pelicano H; Zhou Y; Carew JS; Feng L; Bhalla KN; Keating MJ; Huang P
Cancer Res; 2005 Jan; 65(2):613-21. PubMed ID: 15695406
[TBL] [Abstract][Full Text] [Related]
5. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
Granchi C; Fancelli D; Minutolo F
Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186
[TBL] [Abstract][Full Text] [Related]
6. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.
Talekar M; Boreddy SR; Singh A; Amiji M
Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115
[TBL] [Abstract][Full Text] [Related]
7. Glycolysis-induced drug resistance in tumors-A response to danger signals?
Marcucci F; Rumio C
Neoplasia; 2021 Feb; 23(2):234-245. PubMed ID: 33418276
[TBL] [Abstract][Full Text] [Related]
8. An Update on Patents Covering Agents That Interfere with the Cancer Glycolytic Cascade.
Fortunato S; Bononi G; Granchi C; Minutolo F
ChemMedChem; 2018 Nov; 13(21):2251-2265. PubMed ID: 30226288
[TBL] [Abstract][Full Text] [Related]
9. Targeting hypoxic response for cancer therapy.
Paolicchi E; Gemignani F; Krstic-Demonacos M; Dedhar S; Mutti L; Landi S
Oncotarget; 2016 Mar; 7(12):13464-78. PubMed ID: 26859576
[TBL] [Abstract][Full Text] [Related]
10. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect.
Chen XS; Li LY; Guan YD; Yang JM; Cheng Y
Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491
[TBL] [Abstract][Full Text] [Related]
11. The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?
López-Lázaro M
Anticancer Agents Med Chem; 2008 Apr; 8(3):305-12. PubMed ID: 18393789
[TBL] [Abstract][Full Text] [Related]
12. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
Jiang X; Sun Q; Li H; Li K; Ren X
Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell metabolism: implications for therapeutic targets.
Jang M; Kim SS; Lee J
Exp Mol Med; 2013 Oct; 45(10):e45. PubMed ID: 24091747
[TBL] [Abstract][Full Text] [Related]
14. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
Xintaropoulou C; Ward C; Wise A; Queckborner S; Turnbull A; Michie CO; Williams ARW; Rye T; Gourley C; Langdon SP
BMC Cancer; 2018 Jun; 18(1):636. PubMed ID: 29866066
[TBL] [Abstract][Full Text] [Related]
15. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
[TBL] [Abstract][Full Text] [Related]
16. [Not Available.].
Hofmann E
Acta Hist Leopoldina; 2016; (65):299-369. PubMed ID: 29489123
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor glycolysis by a mitotropic agent.
Ganapathy-Kanniappan S
Expert Opin Ther Targets; 2016; 20(1):1-5. PubMed ID: 26420565
[TBL] [Abstract][Full Text] [Related]
18. Metabolic alterations in cancer cells and therapeutic implications.
Hammoudi N; Ahmed KB; Garcia-Prieto C; Huang P
Chin J Cancer; 2011 Aug; 30(8):508-25. PubMed ID: 21801600
[TBL] [Abstract][Full Text] [Related]
19. Targeting glycolysis in proliferative kidney diseases.
Ghazi S; Polesel M; Hall AM
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1531-F1535. PubMed ID: 31709806
[TBL] [Abstract][Full Text] [Related]
20. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
Shi Y; Liu S; Ahmad S; Gao Q
Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
